Tüchler H - Search Results

1

Serum Vitamin D Levels in Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Analysis.

Müller-Thomas C, Tüchler H, Rudelius M, Schneider H, Pfefferkorn S, Götze KS. Müller-Thomas C, et al. Among authors: tuchler h. Acta Haematol. 2019;141(4):225-231. doi: 10.1159/000496014. Epub 2019 Apr 9. Acta Haematol. 2019. PMID: 30965326 Free article.

2

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.

Braulke F, Platzbecker U, Müller-Thomas C, Götze K, Germing U, Brümmendorf TH, Nolte F, Hofmann WK, Giagounidis AA, Lübbert M, Greenberg PL, Bennett JM, Solé F, Mallo M, Slovak ML, Ohyashiki K, Le Beau MM, Tüchler H, Pfeilstöcker M, Nösslinger T, Hildebrandt B, Shirneshan K, Aul C, Stauder R, Sperr WR, Valent P, Fonatsch C, Trümper L, Haase D, Schanz J. Braulke F, et al. Among authors: tuchler h. Haematologica. 2015 Feb;100(2):205-13. doi: 10.3324/haematol.2014.110452. Epub 2014 Oct 24. Haematologica. 2015. PMID: 25344522 Free PMC article.

3

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.

Braulke F, Müller-Thomas C, Götze K, Platzbecker U, Germing U, Hofmann WK, Giagounidis AA, Lübbert M, Greenberg PL, Bennett JM, Solé F, Slovak ML, Ohyashiki K, Le Beau MM, Tüchler H, Pfeilstöcker M, Hildebrandt B, Aul C, Stauder R, Valent P, Fonatsch C, Bacher U, Trümper L, Haase D, Schanz J. Braulke F, et al. Among authors: tuchler h. Genes Chromosomes Cancer. 2015 Dec;54(12):809-17. doi: 10.1002/gcc.22292. Epub 2015 Sep 10. Genes Chromosomes Cancer. 2015. PMID: 26355708

4

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M. Nösslinger T, et al. Among authors: tuchler h. Blood. 2001 Nov 15;98(10):2935-41. doi: 10.1182/blood.v98.10.2935. Blood. 2001. PMID: 11698274 Free article.

5

Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.

Nösslinger T, Tüchler H, Germing U, Sperr WR, Krieger O, Haase D, Lübbert M, Stauder R, Giagounidis A, Valent P, Pfeilstöcker M. Nösslinger T, et al. Among authors: tuchler h. Ann Oncol. 2010 Jan;21(1):120-5. doi: 10.1093/annonc/mdp264. Epub 2009 Jul 15. Ann Oncol. 2010. PMID: 19605511 Free article.

6

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Pfeilstöcker M, Reisner R, Nösslinger T, Grüner H, Nowotny H, Tüchler H, Schlögl E, Pittermann E, Heinz R. Pfeilstöcker M, et al. Among authors: tuchler h. Br J Haematol. 1999 Aug;106(2):455-63. doi: 10.1046/j.1365-2141.1999.01559.x. Br J Haematol. 1999. PMID: 10460606 Free article.

7

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.

Haase D, Stevenson KE, Neuberg D, Maciejewski JP, Nazha A, Sekeres MA, Ebert BL, Garcia-Manero G, Haferlach C, Haferlach T, Kern W, Ogawa S, Nagata Y, Yoshida K, Graubert TA, Walter MJ, List AF, Komrokji RS, Padron E, Sallman D, Papaemmanuil E, Campbell PJ, Savona MR, Seegmiller A, Adès L, Fenaux P, Shih LY, Bowen D, Groves MJ, Tauro S, Fontenay M, Kosmider O, Bar-Natan M, Steensma D, Stone R, Heuser M, Thol F, Cazzola M, Malcovati L, Karsan A, Ganster C, Hellström-Lindberg E, Boultwood J, Pellagatti A, Santini V, Quek L, Vyas P, Tüchler H, Greenberg PL, Bejar R; International Working Group for MDS Molecular Prognostic Committee. Haase D, et al. Among authors: tuchler h. Leukemia. 2019 Jul;33(7):1747-1758. doi: 10.1038/s41375-018-0351-2. Epub 2019 Jan 11. Leukemia. 2019. PMID: 30635634 Free PMC article.

8

Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Galpha16 and 5'-lipoxygenase.

Pfeilstöcker M, Karlic H, Nösslinger T, Tüchler H, Lohninger A, Pittermann E. Pfeilstöcker M, et al. Among authors: tuchler h. Ann Hematol. 2002 Nov;81(11):632-40. doi: 10.1007/s00277-002-0536-6. Epub 2002 Oct 23. Ann Hematol. 2002. PMID: 12454701

9

Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.

Nösslinger T, Reisner R, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M. Nösslinger T, et al. Among authors: tuchler h. Leuk Res. 2001 Sep;25(9):741-7. doi: 10.1016/s0145-2126(01)00014-5. Leuk Res. 2001. PMID: 11489467

10

Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes.

Pfeilstöcker M, Tüchler H, Schönmetzler A, Nösslinger T, Pittermann E. Pfeilstöcker M, et al. Among authors: tuchler h. Leuk Res. 2012 Feb;36(2):132-9. doi: 10.1016/j.leukres.2011.09.007. Epub 2011 Oct 2. Leuk Res. 2012. PMID: 21967831 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page